Ophthalmologic manifestations commonly misdiagnosed as demyelinating events in multiple sclerosis patients

被引:1
|
作者
Simao, Luciano M. [1 ]
机构
[1] Univ Fed Minas Gerais, Neuroophthalmol Serv, Belo Horizonte, MG, Brazil
关键词
multiple sclerosis; neuroophthalmology examination; ophthalmologic disorders; overlapping visual symptoms; ISCHEMIC OPTIC NEUROPATHY; MYASTHENIA-GRAVIS; VISUAL FUNCTION; EYE; PREVALENCE; DIAGNOSIS; NEURITIS; DISEASE;
D O I
10.1097/ICU.0b013e32833eade6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review Multiple sclerosis may affect both afferent and efferent visual pathways, and sometimes physicians err on ordinary ophthalmologic diagnosis due to overlapping symptoms between demyelinating and nondemyelinating visual diseases. The present article highlights nondemyelinating ocular occurrences due to physiologic or other pathologic processes that may appear in some patients. Recent findings Optic neuritis is representative of the most common and best-studied demyelinating visual occurrence in multiple sclerosis. However, other nondemyelinating visual disturbances also seen in the general population may be erroneously interpreted as being part of the underlying disease. This comparison has not been documented and may be helpful to overcome such difficulties. Summary Based on clinical history and some strategies of ophthalmologic examination, physicians can achieve the correct diagnosis. Some clinical situations, however, may be challenging and a multidisciplinary approach in the care of multiple sclerosis is warranted.
引用
收藏
页码:436 / 441
页数:6
相关论文
共 50 条
  • [1] Multiple sclerosis and neuro-ophthalmologic manifestations
    Cerovski, B
    Vidovic, T
    Petricek, I
    Popovic-Suic, S
    Kordic, R
    Bojic, L
    Cerovski, J
    Kovacevic, S
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 : 153 - 158
  • [2] Evaluation of demographic and neuro-ophthalmologic findings of patients with multiple sclerosis
    Orman, Gozde
    Sungur, Gulten
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [3] Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis
    Gajofatto, A.
    Bongianni, M.
    Zanusso, G.
    Bianchi, M. R.
    Turatti, M.
    Benedetti, M. D.
    Monaco, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (05): : 336 - 344
  • [4] Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis
    Novo, Joana Costa
    Felgueiras, Helena
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [5] Oroal manifestations in patients with multiple sclerosis
    Grajales-Gonazalez, Hilda Mar-A
    Munive-Baez, Leticia
    de la Teja-Angeles, Eduardo
    ACTA PEDIATRICA DE MEXICO, 2013, 34 (05): : 253 - 257
  • [6] ATYPICAL DEMYELINATING LESIONS IN PATIENTS WITH MULTIPLE-SCLEROSIS
    YETKIN, Z
    HAUGHTON, VM
    NEURORADIOLOGY, 1995, 37 (04) : 284 - 286
  • [7] Neuropsychological Manifestations of Multiple Sclerosis
    Hancock, Laura M.
    Rao, Stephen M.
    Galioto, Rachel
    NEUROLOGIC CLINICS, 2024, 42 (04) : 835 - 847
  • [8] Brainstem demyelinating lesions in patients with multiple sclerosis and migraine
    Granato, A
    Zorzon, M
    Locatelli, L
    Maggiore, C
    Bosco, A
    Bratina, A
    Pizzolato, G
    Relja, G
    CEPHALALGIA, 2005, 25 (10) : 911 - 911
  • [9] Initial Cervical Spinal Cord Demyelinating Lesions are not Associated with Restless Legs Syndrome in Patients with Multiple Sclerosis
    Eskut, Neslihan
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Onder, Ozlem
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2023, 26 (06) : 876 - 882
  • [10] Erdheim-Chester disease: misdiagnosed as multiple sclerosis
    Yang, Jason
    Imlay-Gillespie, Louise
    Dierkes, Judith Gerarda
    Khoo, Tien Kheng
    PRACTICAL NEUROLOGY, 2024, 24 (02) : 144 - 147